These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34799492)

  • 1. Sex-Specific Risk Factors and Health Disparity Among Hepatitis C Positive Patients Receiving Pharmacotherapy for Opioid Use Disorder: Findings From a Propensity Matched Analysis.
    Dennis BB; Martin LJ; Naji L; Akhtar D; Cholankeril G; Kim D; Sanger N; Hillmer A; Chawar C; D'Elia A; Panesar B; Worster A; Marsh DC; O'Shea T; Bawor M; Thabane L; Samaan Z; Ahmed A
    J Addict Med; 2022 Jul-Aug 01; 16(4):e248-e256. PubMed ID: 34799492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of the Brief Pain Inventory in Patients with Opioid Addiction Receiving Methadone Maintenance Treatment.
    Dennis BB; Roshanov PS; Bawor M; Paul J; Varenbut M; Daiter J; Plater C; Pare G; Marsh DC; Worster A; Desai D; Thabane L; Samaan Z
    Pain Physician; 2016 Jan; 19(1):E181-95. PubMed ID: 26752486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of chronic liver disease in patients receiving active pharmacological therapy for opioid use disorder: One-year findings from a prospective cohort study.
    Dennis BB; Akhtar D; Cholankeril G; Kim D; Sanger N; Hillmer A; Chawar C; D'Elia A; Panesar B; Worster A; Marsh DC; Thabane L; Samaan Z; Ahmed A
    Drug Alcohol Depend; 2020 Apr; 209():107917. PubMed ID: 32088589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C Cascade of Care Among Pregnant Women on Opioid Agonist Pharmacotherapy Attending a Comprehensive Prenatal Program.
    Page K; Leeman L; Bishop S; Cano S; Bakhireva LN
    Matern Child Health J; 2017 Sep; 21(9):1778-1783. PubMed ID: 28699096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysis.
    McLinden T; Moodie EEM; Hamelin AM; Harper S; Rossi C; Walmsley SL; Rourke SB; Cooper C; Klein MB; Cox J
    Drug Alcohol Depend; 2018 Apr; 185():374-380. PubMed ID: 29544189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users.
    Tsui JI; Evans JL; Lum PJ; Hahn JA; Page K
    JAMA Intern Med; 2014 Dec; 174(12):1974-81. PubMed ID: 25347412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis.
    Hajarizadeh B; Cunningham EB; Valerio H; Martinello M; Law M; Janjua NZ; Midgard H; Dalgard O; Dillon J; Hickman M; Bruneau J; Dore GJ; Grebely J
    J Hepatol; 2020 Apr; 72(4):643-657. PubMed ID: 31785345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial.
    Radley A; de Bruin M; Inglis SK; Donnan PT; Hapca A; Barclay ST; Fraser A; Dillon JF
    Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):809-818. PubMed ID: 32526210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs.
    Rosenthal ES; Silk R; Mathur P; Gross C; Eyasu R; Nussdorf L; Hill K; Brokus C; D'Amore A; Sidique N; Bijole P; Jones M; Kier R; McCullough D; Sternberg D; Stafford K; Sun J; Masur H; Kottilil S; Kattakuzhy S
    Clin Infect Dis; 2020 Oct; 71(7):1715-1722. PubMed ID: 32009165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: Telemedicine for Evaluation, Adherence and Medication for Hepatitis C (TEAM-C).
    Talal AH; Markatou M; Sofikitou EM; Brown LS; Perumalswami P; Dinani A; Tobin JN
    Contemp Clin Trials; 2022 Jan; 112():106632. PubMed ID: 34813962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City.
    Jordan AE; Cleland CM; Wyka K; Schackman BR; Perlman DC; Nash D
    J Infect Dis; 2020 Sep; 222(Suppl 5):S322-S334. PubMed ID: 32877567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Socio-Demographic and Health Functioning Variables Among Patients with Opioid Use Disorder Introduced by Prescription: A Prospective Cohort Study.
    Sanger N; Bhatt M; Shams I; Shahid H; Luo C; Tam SL; Samaan MC; de Souza R; Thabane L; Samaan Z
    Pain Physician; 2018 Nov; 21(6):E623-E632. PubMed ID: 30508993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C Virus Screening among Medicaid-Insured Individuals with Opioid Use Disorder across Substance Use Disorder Treatment Settings.
    Choi S; Healy S; Shapoval L; Forthal S; Neighbors CJ
    Subst Use Misuse; 2021; 56(2):258-263. PubMed ID: 33345680
    [No Abstract]   [Full Text] [Related]  

  • 14. Personality dysfunction in opiate addicts on opioid substitution treatment and the risk of HCV infection.
    Skočibušić S; Zivlak-Radulović N; Hasanović M; Awad H; Karan-Križanac D; Mehić-Basara N; Rukavina T
    Front Public Health; 2022; 10():1009413. PubMed ID: 36159261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use.
    Spaderna M; Kattakuzhy S; Kang SJ; George N; Bijole P; Ebah E; Eyasu R; Ogbumbadiugha O; Silk R; Gannon C; Davis A; Cover A; Gayle B; Narayanan S; Pao M; Kottilil S; Rosenthal E
    Int J Drug Policy; 2023 Jan; 111():103906. PubMed ID: 36384062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated, Co-located, Telemedicine-based Treatment Approaches for Hepatitis C Virus Management in Opioid Use Disorder Patients on Methadone.
    Talal AH; Andrews P; Mcleod A; Chen Y; Sylvester C; Markatou M; Brown LS
    Clin Infect Dis; 2019 Jul; 69(2):323-331. PubMed ID: 30329042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006-2016.
    Socías ME; Wood E; Kerr T; Nolan S; Hayashi K; Nosova E; Montaner J; Milloy MJ
    Drug Alcohol Depend; 2018 Aug; 189():90-95. PubMed ID: 29894910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low risk for hepatitis C seroconversion in methadone maintenance treatment.
    Peles E; Schreiber S; Rados V; Adelson M
    J Addict Med; 2011 Sep; 5(3):214-20. PubMed ID: 21844836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C Virus Testing and Treatment Among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders.
    Carey KJ; Huang W; Linas BP; Tsui JI
    J Subst Abuse Treat; 2016 Jul; 66():54-9. PubMed ID: 26988423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C Virus (HCV) Care Continuum Outcomes and HCV Community Viral Loads Among Patients in an Opioid Treatment Program.
    Jordan AE; Cleland CM; Schackman BR; Wyka K; Perlman DC; Nash D
    J Infect Dis; 2020 Sep; 222(Suppl 5):S335-S345. PubMed ID: 32877560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.